Last year, Houghton Hutcheson, now 79, started experiencing shortness of breath on a trip to Colorado. When he returned, he scheduled a visit with his primary care physician, Eric Thomas, MD, MPH, ...
Because evidence gaps in idiopathic pulmonary fibrosis research hinder demonstration of antifibrotic therapies’ impact on patient quality of life (QOL), integrating validated health-related QOL ...
A new study suggests that COVID-19 may slightly increase the risk of lung cancer by triggering a biological chain reaction in the lungs, driven by the virus's spike protein, that promotes inflammation ...